54 Search Results

q=Ovarian

Search Again


M. Robyn Andersen , PhD, MPH

Email: rander@fredhutch.org

Phone: (206) 667-6684

Dr. Andersen's research examines issues related to the adoption of medical technologies for the prevention and treatment of cancer. She is currently involved in projects examining psychosocial predictors of quality of life for breast and ovarian cancer survivors, the influence of Complimentary and Alternative (CAM) on cancer diagnosis and treatment and the potential of a symptoms index to improve early diagnosis of ovarian cancer.

View Bio

Garnet Anderson , PhD

Email: garnet@whi.org

Phone: (206) 667-4699

Dr. Anderson's area of expertise are to design, analyze, and conduct randomized trials and Biostatistics. Her research interest is focused on Women's health; in particular in the area of prevention of chronic disease, health effects of menopausal hormone therapy, ovarian cancer, including biomarkers, screening, and risk.

View Bio

Mike Averkiou , PhD

Email: maverk@uw.edu

Phone: (206) 616-9558

Dr. Averkiou develops new ultrasound imaging and therapy technology for disease detection, improved cancer treatment and monitoring, improved drug delivery to targeted cells, and heart disease. Using advanced nonlinear imaging techniques and microbubble contrast agents, he is able to detect the earliest stages of tumor angiogenesis and atherosclerosis, and closely monitor their treatment. He focuses on transferring innovations from preclinical research into clinical use.

View Bio

Geoffrey Baird , MD, PhD

Email: gbaird@uw.edu

Phone: (206)744-9787

Dr. Baird's clinical interests include laboratory test utilization, molecular diagnostics, proteomics and immunohistochemistry. His group has developed a new proteomic technology for biomarker discovery in a range of diseases such as malignancies, cardiovascular disorders, and inflammatory conditions. One application of their technology is to discover protein expression changes associated with non-small cell lung cancer that have implications for diagnosis and treatment.

View Bio

Laura Mae Baldwin , MD, MPH

Email: lmb@u.washington.edu

Phone: (206) 685-4799

Dr. Baldwin is a health services researcher with a focus on access to and quality of health care in diverse underserved and rural areas. Her areas of interest are cancer prevention and treatment, and perinatal health, all with an eye towards ensuring equitable access to high quality health services across U.S.

View Bio

Parveen Bhatti , PhD

Email: pbhatti@fredhutch.org

Phone: (206) 667-7803

Dr. Bhatti's research focus is on occupational and environmental epidemiology of cancer with a focus in biomarkers of exposure, susceptibility and disease; particularly genetic susceptibility to cancer following low dose exposure to occupational or medical ionizing radiation.

View Bio

Jason Bielas , PhD

Email: jbielas@fredhutch.org

Dr. Bielas leads a group group studies the fundamental and clinical implications of nuclear and mitochondrial DNA mutations in the pathogenesis of cancer and age-related disease including breast and ovarian cancer. Recently, his laboratory has developed a new test for predicting ovarian cancer survival.

View Bio

Hamid Bolouri , PhD

Email: hbolouri@fredhutch.org

Phone: (206) 667-2748

Dr. Bolouri is interested in understanding how gene regulatory interactions control cellular state and identity, both in normal development and in diseases such as cancer. A particular focus of his lab is the development and use of integrative computational systems biology methods to map gene regulatory networks from whole genome data: currently they are working on identification of cis-regulatory sequence variations in childhood Acute Myeloid Leukemia.

View Bio

Lynn Bonham , PhD

Email: lbonham@seattlecca.org

Phone: (206)288-2022

Dr. Bonham directs and manages Cellular Therapeutics at SCCA, which processes cells from peripheral blood, bone marrow and cord blood for standard transplantations and clinical trials for cancer treatment.

View Bio

Roger Brent , PhD

Email: rbrent@fredhutch.org

Phone: (206) 667-1482

Dr. Brent studies the quantitative operation of the systems that living cells use to sense, represent, transmit, and act upon information to make decisions that determine their future fates. He specifically studies prototypic cell signaling systems in budding yeast and the pheromone response system; he has extended similar work to systems operating in single cells of tissues in a metazoan, Caenorhabditis elegans.

View Bio

Peter Brzovic , PhD

Email: brzovic@u.washington.edu

Phone: (206) 685-1550

Dr. Brzovic specializes in biochemical structural techniques like the Nuclear Magnetic Resonance (NMR). As a part of the Klevit group, Dr. Brzovic studies protein-protein interactions involved in protein quality control and repair, in particular, the interaction between ubiquitin-conjugating enzymes and ubiquitin ligases. Deleterious mutations in key participants of these intracellular pathways frequently result in the manifestation of cancer, cataracts, myopathy, and many other forms of chronic disease.

View Bio

Mac Cheever , MD

Email: mcheever@fredhutch.org

Phone: (206) 667-4141

Dr. Cheever's specialty is in the areas of medical oncology, immunotherapy and solid tumor research. His current research interests are in conducting cancer clinical trials to develop and test new immunotherapies. He also interested on developing the principles of T cell therapy, cancer antigen discovery and development of cancer vaccines, especially for breast cancer.

View Bio

James Dai , PhD

Email: jdai@fredhutch.org

Phone: (206) 667-6364

James Dai’s Lab works in statistical genetics and genomics, design and analysis of randomized clinical trials, statistical methods for high-dimensional feature selection and prediction, gene-treatment interaction, mediation and instrumental variables regression. Methodologically, his lab is also interested in cancer genomics topics, for example integrative genomic analyses and intra-tumor heterogeneity. The overarching scientific interest is to discover and validate and genomic markers that drive cancer etiology, predict cancer prognosis and treatment efficacy.

View Bio

Kemi Doll , MD, MCSR

Email: kdoll@uw.edu

Phone: 206-543-3669

Kemi M. Doll, M.D., M.C.S.R. is a Gynecologic Oncologist in the UW Department of Obstetrics and Gynecology. She specializes in the surgical and medical treatment of uterine, ovarian, cervical and vulvar cancers. Dr. Doll's clinical interests include surgery, chemotherapy, and hormonal therapy for gynecologic cancers; and minimally invasive and robotic surgery.

View Bio

Charles Drescher , MD

Email: cdresche@fredhutch.org

Phone: (206) 667-7459

Dr. Drescher is a gynecologic cancer specialist who treats women with gynecologic cancers, as well as women with complex benign gynecological conditions. His areas of expertise include: Cervical Cancer, da Vinci (Robot-Assisted Surgery), Endometrial Cancer, Endometriosis, Fibroids, Gynecologic Cancer Surgery (Robotic), Hysterectomy (Robotic), Ovarian Cancer, Pelvic Prolapse. In addition, he co-leads a SPORE project focused on molecular targets for ovarian cancer prognosis and therapy.

View Bio

Marianne Dubard-Gault , MD, MS

Email: mdg2019@uw.edu

Dr. Dubard-Gault is the medical director of the Cancer Genetics Program at SCCA. Her main research interest is to better understand how genetic information influences patients’ decision-making about health care and life choices. She is also interested in exploring ways to help people better access medical genetic information, talk about it with their families and use that knowledge to make decisions that fit their goals.

View Bio

Gary Goodman , MD, MS

Email: gary.goodman@swedish.org

Phone: (206) 667-5722

Dr. Goodman is specialized in internal medicine. His clinical interests are: General Medical Oncology, Lung Cancer, Melanoma, Ovarian Cancer, Renal Cell Cancer and Sarcoma.

View Bio

Holly Harris , MPH, ScD

Email: hharris@fredhutch.org

Phone: (206) 667-2712

Dr. Harris is broadly interested in the impact of lifestyle, nutrition, and genetic factors on women’s health. Specifically, she has focused on ovarian and breast cancer, as well as on hormonally related conditions that have shared reproductive risk factors with these diseases, including endometriosis and uterine fibroids. Much of her research to date has focused on understanding the role of the potentially modifiable risk factors of diet and lifestyle on the risk of these conditions. A more recent facet of Dr. Harris' research is to explore the interrelatedness of these conditions and their shared risk factors. As ovarian cancer is rare, she is particularly interested in identifying women, such as those with endometriosis or polycystic ovary syndrome (PCOS), who may be at higher risk because these women may benefit from screening modalities for ovarian cancer which are currently not appropriate for population-based use. Identification of women at high risk for ovarian cancer and breast cancer is also important as it allows for targeted prevention strategies and can guide clinical decisions regarding frequency of screening and chemoprevention strategies for both of these cancers. Finally, understanding the influence of genetic factors, both alone or as a part of gene-environment interactions may facilitate prevention and help identify women most at risk for ovarian and breast cancer.

View Bio

Noah Hoffman , MD, PhD

Email: ngh2@uw.edu

Phone: (206) 598-7932

Dr. Hoffman's clinical interests and responsibilities include the development and application of software and processes for the collection, management, and display of data generated in the clinical laboratory. His research is focused on creating applications and algorithms to classify medically important microorganisms using biological sequence information.

View Bio